Cite
Hendrayana T, Wilmer A, Kurth V, et al. Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application. Sci Pharm. 2017;85(1)doi: 10.3390/scipharm85010008.
Hendrayana, T., Wilmer, A., Kurth, V., Schmidt-Wolf, I. G., & Jaehde, U. (2017). Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application. Scientia pharmaceutica, 85(1), . https://doi.org/10.3390/scipharm85010008
Hendrayana, Tomi, et al. "Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application." Scientia pharmaceutica vol. 85,1 (2017). doi: https://doi.org/10.3390/scipharm85010008
Hendrayana T, Wilmer A, Kurth V, Schmidt-Wolf IG, Jaehde U. Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: From Scientific Evidence to Clinical Application. Sci Pharm. 2017 Feb 27;85(1). doi: 10.3390/scipharm85010008. PMID: 28264440; PMCID: PMC5388145.
Copy
Download .nbib